Exact Sciences
EXAS
#1154
Rank
A$28.87 B
Marketcap
A$152.15
Share price
-0.07%
Change (1 day)
56.74%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: A$28.87 Billion

As of December 2025 Exact Sciences has a market cap of A$28.87 Billion. This makes Exact Sciences the world's 1154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2025

End of year Market Cap

Year Marketcap Change
2025A$28.87 B68.61%
2024A$17.12 B-12.8%
2023A$19.63 B51.91%
2022A$12.92 B-30.66%
2021A$18.64 B-28.06%
2020A$25.91 B32.92%
2019A$19.49 B76.72%
2018A$11.03 B36.94%
2017A$8.05 B301.02%
2016A$2.00 B64.04%
2015A$1.22 B-58.78%
2014A$2.97 B217.4%
2013A$0.93 B43.75%
2012A$0.65 B55.37%
2011A$0.41 B36.49%
2010A$0.30 B129.08%
2009A$0.13 B508.96%
2008A$22.01 M-77.98%
2007A$99.95 M3.98%
2006A$96.13 M20.39%
2005A$79.84 M-38.62%
2004A$0.13 B-50.51%
2003A$0.26 B-28.29%
2002A$0.36 B-2.7%
2001A$0.37 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Exact Sciences was reported to be:

A$28.82 Billion
by Nasdaq info icon info icon
A$28.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Myriad Genetics
MYGN
A$0.99 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$1.43 B-95.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
A$5.30 B-81.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A$1.71 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$182.01 B 530.41%๐Ÿ‡ซ๐Ÿ‡ท France